Results 251 to 260 of about 2,507,641 (307)

Futility of resection after neoadjuvant therapy in pancreatic ductal adenocarcinoma. [PDF]

iScience
Luo HT, Xie ZQ, Chen SJ, Yu QQ, Xu XY, Wu J, Teng TH.   +6 more
europepmc   +1 more source

Prognostic Determinants of Overall Survival After Resection for Pancreatic Ductal Adenocarcinoma: A Consensus‐Based Conceptual Framework

Journal of Surgical Oncology, EarlyView.
ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis despite surgical resection, yet the prognostic literature remains fragmented across hundreds of single‐institution studies that vary in design, covariates, and analytical approaches.
Muhammad Maisam Ali, Kaleem S. Ahmed, Clayton T. Marcinak, Syed Ali Tayyeb Hasan, Anne D. Letocha, Noorain Ahmad, Haider bin Khalid, Kainat Fatima, Syed Nabeel Zafar   +8 more
wiley   +1 more source

Comparison of Thrombocytopenia and Splenomegaly in Locally Advanced Rectal Cancer Patients Receiving Total Neoadjuvant Therapy With and Without Immunotherapy. [PDF]

Cancer Med
Li S, Yan M, Ma Q, Sun Y, Zhang Z, Shen L, Wan J, Zhang H, Wu R, Xia F, Wang Y.   +10 more
europepmc   +1 more source

Factors Associated With Receipt of Adjuvant Radiation in Locally Advanced Rectal Cancer

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background Neoadjuvant radiotherapy (RT) has been the standard of care for locally advanced rectal cancer (LARC) for over two decades. Adjuvant RT use in LARC represents a deviation from standard care and warrants further investigation. Objectives To identify factors associated with adjuvant RT utilization.
Maryam Sherwani, Danish Ali, Hanjoo Lee, Alexander T. Hawkins, Aimal Khan   +4 more
wiley   +1 more source

Ultrasound and Clinicopathological Features-Based Machine Learning Model for Predicting Neoadjuvant Therapy Efficacy in Breast Cancer. [PDF]

Cancer Rep (Hoboken)
Hao T, Ji X, Zhao Q, Wei M.
europepmc   +1 more source

Oncoplastic Surgery Versus Total Breast Reconstruction in Locally Advanced and Multicentric Carcinomas. A Matched Comparative Cohort Study of Oncologic and Aesthetic Outcomes

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background/Objective This study aimed to compare extreme oncoplastic surgery (EO‐partial breast reconstruction for tumors > 5 cm or multicentric lesions) with extreme reconstruction (ER‐mastectomy with reconstruction for tumors >5 cm or multicentric lesions).
Aline Regina Nunes‐Reis, Regis Resende Paulinelli, Rosemar Macedo Sousa Rahal, Luiz Fernando Jubé Ribeiro, Ruffo de Freitas Júnior   +4 more
wiley   +1 more source

Tumor genome and microenvironment alteration by trastuzumab deruxtecan as neoadjuvant therapy for HER2-mutant NSCLC. [PDF]

Sci Rep
Li J, Lu X, Yue S, Hang R, Dai X, Kuang X, Guo W, Huang Z, Xiong Y, Li M.   +9 more
europepmc   +1 more source

Organ preservation with total neoadjuvant therapy in early-stage rectal cancer: A statewide analysis. [PDF]

Colorectal Dis
Bunjo Z, Fitzsimmons T, Nguyen TM, Penniment M, Selva-Nayagam S, Tonkin D, Sia TC, Murphy E, Thomas M, Sammour T.   +9 more
europepmc   +1 more source

Residual disease after neoadjuvant therapy in HER2-positive breast cancer: biology, burden, or both? [PDF]

Transl Cancer Res
Di Lena É, Takabe K.
europepmc   +1 more source

Development and Validation of a Pathomics Model for Prognosis Prediction in Neoadjuvant Therapy-Treated Breast Cancer: A Retrospective, Multicenter Study. [PDF]

MedComm (2020)
Wei Y, Lou W, Han Z, Yang F, Li F, Li H, Shi H, Wei B, Li H, Zhao Y, Xiao X, Yang Y, Han A, Yao J, Bu H.   +14 more
europepmc   +1 more source